FindTrial
Sign In

AI based prognostic evaluation of novel coronavirus pneumonia (COVID-19)

AI based prognostic evaluation of novel coronavirus pneumonia (COVID-19)

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2000031336
Enrollment
Unknown
Registered
2020-03-28
Start date
2020-04-12
Completion date
Unknown
Last updated
2020-03-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Novel Coronavirus Pneumonia (COVID-19)

Interventions

Gold Standard:Clinical outcome by diagnosis results of imaging doctors and clinicians
Index test:new&#32
artificial&#32
intelligence-based&#32
prognosis&#32
assessment&#32
system

Sponsors

Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 90 Years

Inclusion criteria

Inclusion criteria: 1) Positive; 2) There is a CT examination in our hospital.

Exclusion criteria

Exclusion criteria: 1) Those with poor CT image quality; 2) Patients who are unwilling to participate in the study.

Design outcomes

Primary

MeasureTime frame
sensitivity;accuracy;specificity;—

Countries

China

Contacts

Public ContactFan Yang

Union Hospital, Tongji Medical College, Huazhong University of Science and Technology

fyang@vip.163.com+86 027 85726309

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026